HTR5A and irritable bowel syndrome: Clinical studies have shown increased number and activation of mast cells in patients with IBS, which release various mediators, including pro-inflammatory cytokines and 5-HT, to alter intestinal sensation, motility, secretion, and permeability (Krammer et al., 2019).